Autologous Ex Vivo Lentiviral Gene Therapy for the Treatment of ADA-SCID

被引：0

作者：

Booth, Claire ^{[1
]}

Kohn, Don B. ^{[2
]}

Shaw, Kit L. ^{[2
]}

Xu-Bayford, Jinhua ^{[3
]}

Garabedian, Elizabeth ^{[4
]}

Trevisan, Valentina ^{[1
]}

Carbonaro-Sarracino, Denise A. ^{[5
]}

Soni, Kajal ^{[1
]}

Terrazas, Dayna ^{[2
]}

Snell, Katie ^{[5
]}

Leon-Rico, Diego ^{[1
]}

Buckland, Karen ^{[1
]}

Gilmour, Kimberly ^{[1
]}

De Oliveira, Satiro ^{[2
]}

Rivat, Christine ^{[5
]}

Izotova, Natalia ^{[1
]}

Adams, Stuart ^{[1
]}

Ricketts, Hilory ^{[1
]}

Davila, Alejandra ^{[2
]}

Uzowuru, Chilenwa ^{[1
]}

Fernandez, Beatriz Campo ^{[2
]}

Hollis, Roger P. ^{[2
]}

Coronel, Maritess ^{[2
]}

Zhang, Ruixue ^{[2
]}

Arduini, Serena ^{[5
]}

Lynn, Frances ^{[5
]}

Kudari, Mahesh ^{[5
]}

Spezzi, Andrea ^{[5
]}

Zhan, Marco ^{[6
]}

Heimke, Rene ^{[6
]}

Labik, Ivan ^{[6
]}

Cornetta, Kenneth ^{[7
]}

Sokolic, Robert ^{[4
]}

Hershfield, Michael ^{[8
]}

Schmidt, Manfred ^{[6
]}

Candotti, Fabio ^{[9
]}

Malech, Harry L. ^{[10
]}

Thrasher, Adrian J. ^{[1
]}

Gaspar, H. Bobby ^{[5
]}

机构：

[1] UCL GOSH Inst Child Hlth, London, England

[2] Univ Calif Los Angeles, Los Angeles, CA USA

[3] Great Ormond St Hosp NHS Trust, London, England

[4] NHGRI, Bethesda, MD 20892 USA

[5] Orchard Therapeut, London, England

[6] GeneWerk, Heidelberg, Germany

[7] Indiana Univ Sch Med, Indianapolis, IN 46202 USA

[8] Duke Univ, Durham, NC USA

[9] Lausanne Univ Hosp, Lausanne, Switzerland

[10] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA

来源：

MOLECULAR THERAPY | 2021年 / 29卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：20 / 20

页数：1

共 50 条

[31] Long-Term Safety and Efficacy of Retroviral-Mediated Gene Therapy for ADA-SCID
Cicalese, M. P.
Ferrua, F.
Pajno, R.
Barzaghi, F.
Frittoli, M.
Castagnaro, L.
Giannelli, S.
Dionisio, F.
Brigida, I.
Tabucchi, A.
Carlucci, F.
Hogg, A.
Singh, K.
Campanile, A.
Philipson, R.
Appleby, J.
Roncarolo, M. G.
Aiuti, A.
[J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S311 - S311
[32] Stable and Clinically Benign Clonal Dominance in an ADA-SCID Patient Treated With Retroviral Gene Therapy
Cooper, Aaron R.
Shaw, Kit L.
Lill, Georgia R.
Sokolic, Robert
Candotti, Fabio
Kohn, Donald B.
[J]. MOLECULAR THERAPY, 2015, 23 : S94 - S94
[33] Correction of the long-term immunologic and metabolic defects after gene therapy for ADA-SCID
Aiuti, A.
Galimberti, S.
Cattaneo, F.
Biral, E.
Frugnoli, I
Brigida, I
Cassani, B.
Casiraghi, M.
Callegaro, L.
Ferrua, F.
Carlucci, F.
Rossi, P.
Cappelli, B.
Chiesa, R.
Marktel, S.
Valsecchi, M. G.
Miniero, R.
Bordignon, C.
Ciceri, F.
Roncarolo, M. G.
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : S49 - S49
[34] Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients
Cooper, Aaron R.
Lill, Georgia R.
Shaw, Kit
Carbonaro-Sarracino, Denise A.
Davila, Alejandra
Sokolic, Robert
Candotti, Fabio
Pellegrini, Matteo
Kohn, Donald B.
[J]. BLOOD, 2017, 129 (19) : 2624 - 2635
[35] Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Kaiser, Robert A.
Mao, Shennen A.
Glorioso, Jaime
Amiot, Bruce
Nicolas, Clara T.
Allen, Kari L.
Du, Zeji
VanLith, Caitlin J.
Hickey, Raymond D.
Nyberg, Scott L.
Lillegard, Joseph B.
[J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (141):
[36] Autologous Ex Vivo Lentiviral Gene Therapy for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency
Kohn, Donald B.
Shaw, Kit L.
Garabedian, Elizabeth K.
Carbonaro-Sarracino, Denise A.
Moore, Theodore B.
De Oliveira, Satiro
Crooks, Gay M.
Tse, John
Shupien, Sally
Terrazas, Dayna
Davila, Alejandra
Icreverzi, Amalia
Yu, Allen
Barman, Provaboti
Coronel, Maritess
Fernandez, Beatriz Campo
Zhang, Ruixue
Hollis, Roger
Uzowuru, Chilenwa
Ricketts, Hilory
Xu-Bayford, Jinhua
Trevisan, Valentina
Arduini, Serena
Lynn, Frances
Kudari, Mahesh
Spezzi, Andrea
Reeves, Lilith
Cornetta, Kenneth
Sokolic, Robert
Parrott, Roberta
Buckley, Rebecca
Booth, Claire
Candotti, Fabio
Malech, Harry L.
Thrasher, Adrian J.
Gaspar, H. Bobby
[J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2019, 39 : S42 - S44
[37] LONG-TERM IN-VIVO EXPRESSION OF RETROVIRALLY TRANSFERRED ADA GENES IN LYMPHOCYTE CLONES FROM AN ADA-SCID PATIENT TREATED WITH GENE-THERAPY
MULLEN, CA
SNITZER, K
BLAESE, RM
[J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 240 - 240
[38] Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clones
Uchiyama, Toru
Takahashi, Sirirat
Nakabayashi, Kazuhiko
Okamura, Kohji
Edasawa, Kaori
Yamada, Masafumi
Watanabe, Nobuyuki
Mochizuki, Emi
Yasuda, Toru
Miura, Akane
Kato, Motohiro
Tomizawa, Daisuke
Otsu, Makoto
Ariga, Tadashi
Onodera, Masafumi
[J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 23 : 424 - 433
[39] Correction of the immune and metabolic defect of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
Aiuti, A
Gaetaniello, L
Cattaneo, F
Ficara, F
Andolfi, G
Cassani, B
Tabucchi, A
Carlucci, F
Miniero, R
Aker, M
Slavin, S
Roncarolo, MG
Bordignon, C
[J]. MOLECULAR THERAPY, 2003, 7 (05) : S448 - S448
[40] Reconstitution of thymic function after gene therapy for ADA-SCID: preliminary observations by imaging and immunological studies
Ferrua, F.
Brigida, I
Cassani, B.
Casiraghi, M.
de Iorgi, V.
Paesano, P. L.
Roncarolo, M. G.
Aiuti, A.
[J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 154 : 3 - 4

← 1 2 3 4 5 →